Sexual dimorphism of somatostatin and growth hormone-releasing factor signaling in the control of pulsatile growth hormone secretion in the rat.
Painson. J C JC; Tannenbaum. G S GS
Key Findings
- Male rats show a bigger GH response to GRF during peak secretion times because somatostatin is low, while females show no time‑dependent difference.
- Neutralizing somatostatin raises GH nadir levels in males but dramatically increases both peak and baseline GH in females.
- Blocking GRF eliminates spontaneous GH pulses in both sexes and reduces basal GH in females, indicating GRF helps maintain higher baseline GH in females.
Practical Outcomes
- The study suggests that sex differences affect how GH can be modulated. In theory, somatostatin blockers might boost GH more effectively in females, while GRF supplementation could support basal GH levels, especially in women. However, these findings are from rats, so direct human protocols are uncertain and would need careful validation.
Summary
In rats, the way the brain controls growth hormone (GH) differs between males and females. Males have a rhythmic release of the inhibitory hormone somatostatin, which makes GH spikes bigger when somatostatin is low. Females release somatostatin more continuously, so blocking it raises GH levels all the time. Removing the stimulating hormone GRF stops GH pulses in both sexes, and in females it also lowers the baseline GH level.
Abstract
A striking sexual dimorphism exists in the pattern of GH secretion and rate of somatic growth; however, the mechanism(s) mediating this sex difference is unknown. To elucidate the physiological roles of the hypothalamic neuropeptides, somatostatin (SRIF) and GRF, and their interrelation, in generating the sexually dimorphic GH secretory pattern we examined: 1) GH responsiveness to exogenous GRF and 2) the effects of immunoneutralization of endogenous SRIF and GRF on GH secretory dynamics, in free-moving male and female rats. In males, the GH response to 1 microgram rat(r)GRF(1-29)NH2 iv was significantly greater at peak compared to trough times of GH secretion (925.2 +/- 250.8 vs. 95.6 +/- 27.8 ng/ml; P less than 0.02), the latter known to be due to antagonization by the cyclic increased release of endogenous SRIF. In contrast, females failed to exhibit a time-dependent difference in GH responsiveness to GRF. Passive immunization with a specific antiserum to SRIF in males resulted in significant elevation of GH nadir levels but had no effect on GH peak amplitude. In contrast, immunoneutralization of endogenous SRIF in females caused a marked augmentation of plasma GH levels at all time points; there was a significant increase in GH peak amplitude (171.3 +/- 39.9 vs. 67.5 +/- 11.3 ng/ml; P less than 0.05), GH nadir (18.3 +/- 2.7 vs. 5.8 +/- 1.1 ng/ml; P less than 0.01) and mean 6-h plasma GH level (78.7 +/- 4.1 vs. 33.1 +/- 5.8 ng/ml; P less than 0.001), compared to normal sheep serum-treated controls. These results indicate that the pattern of hypothalamic SRIF secretion in females does not follow the male-like ultradian rhythm. Passive immunization with a specific antiserum to GRF obliterated spontaneous GH pulses in both sexes. Moreover, in females, anti-GRF serum attenuated GH nadir levels (4.3 +/- 1.7 vs. 21.4 +/- 3.5 ng/ml; P less than 0.01) indicating a physiological role for GRF in maintaining the elevated basal GH level of females, in addition to its important role in generating the episodic GH pulses. Taken together, these findings provide support for the hypothesis that, in female rats, the pattern of hypothalamic SRIF secretion into hypophyseal portal blood is continuous, rather than cyclical, as in the male; whereas in the case of GRF secretion, in addition to steady-state release which occurs at a higher level in females than males, there is also episodic GRF bursting which does not follow a specific rhythm, as in the male.(ABSTRACT TRUNCATED AT 400 WORDS)
Study Information
pubmed
1991
10.1210/endo-128-6-2858